(CURI) Curiositystream - Ratings and Ratios
Documentary, Educational, Streaming, Video, Audio, Content
CURI EPS (Earnings per Share)
CURI Revenue
Description: CURI Curiositystream
CuriosityStream Inc. (NASDAQ:CURI) is a media and entertainment company that specializes in providing factual content across various categories, including science, history, and technology, through multiple channels and devices. The companys content is accessible via direct subscription video on-demand (SVoD) platforms, distribution partners, and bundled content licenses.
From a business perspective, CuriosityStreams revenue model is diversified across different distribution channels, including direct-to-consumer subscriptions, distribution partnerships, and bulk sales. This diversification can help mitigate risks associated with dependence on a single revenue stream. Key performance indicators (KPIs) to monitor include subscriber growth rate, revenue growth rate, and the percentage of revenue contributed by each distribution channel.
In terms of competitive positioning, CuriosityStream operates in the niche market of factual entertainment, which can be less competitive than the broader entertainment market. The companys focus on factual content can be a differentiator, attracting a dedicated audience interested in educational and informative programming. To assess the companys competitive strength, KPIs such as market share, customer retention rate, and content acquisition costs can be analyzed.
From a financial perspective, CuriosityStreams market capitalization and revenue growth can be used to evaluate its scale and growth prospects. The companys negative return on equity (RoE) indicates that it is currently unprofitable, which may be a concern for investors. Other KPIs to monitor include the companys cash burn rate, operating expenses as a percentage of revenue, and the ratio of debt to equity.
To further evaluate CuriosityStreams prospects, its essential to analyze its content library, content acquisition strategy, and the effectiveness of its marketing efforts. KPIs such as the size and growth of the content library, the average cost per title, and the return on investment (ROI) of marketing campaigns can provide valuable insights into the companys operational efficiency and future prospects.
CURI Stock Overview
| Market Cap in USD | 265m |
| Sub-Industry | Movies & Entertainment |
| IPO / Inception | 2020-01-08 |
CURI Stock Ratings
| Growth Rating | 58.4% |
| Fundamental | 55.0% |
| Dividend Rating | 72.3% |
| Return 12m vs S&P 500 | 135% |
| Analyst Rating | 4.0 of 5 |
CURI Dividends
| Dividend Yield 12m | 8.87% |
| Yield on Cost 5y | 3.66% |
| Annual Growth 5y | 100.00% |
| Payout Consistency | 100.0% |
| Payout Ratio | 0.0% |
CURI Growth Ratios
| Growth Correlation 3m | -50.1% |
| Growth Correlation 12m | 82.8% |
| Growth Correlation 5y | -51.5% |
| CAGR 5y | 51.22% |
| CAGR/Max DD 3y | 0.67 |
| CAGR/Mean DD 3y | 1.44 |
| Sharpe Ratio 12m | -0.04 |
| Alpha | 204.33 |
| Beta | 0.613 |
| Volatility | 75.78% |
| Current Volume | 623.1k |
| Average Volume 20d | 623.1k |
| Stop Loss | 4.5 (-6.3%) |
| Signal | 0.57 |
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income (-4.77m TTM) > 0 and > 6% of Revenue (6% = 3.65m TTM) |
| FCFTA 0.13 (>2.0%) and ΔFCFTA 30.42pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 26.36% (prev 44.98%; Δ -18.62pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.13 (>3.0%) and CFO 10.0m > Net Income -4.77m (YES >=105%, WARN >=100%) |
| Net Debt (17.9m) to EBITDA (2.28m) ratio: 7.86 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.66 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (57.4m) change vs 12m ago 6.98% (target <= -2.0% for YES) |
| Gross Margin 53.07% (prev 46.40%; Δ 6.66pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 71.78% (prev 60.30%; Δ 11.47pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -4.12 (EBITDA TTM 2.28m / Interest Expense TTM 2.58m) >= 6 (WARN >= 3) |
Altman Z'' -24.32
| (A) 0.20 = (Total Current Assets 40.5m - Total Current Liabilities 24.4m) / Total Assets 78.7m |
| (B) -4.05 = Retained Earnings (Balance) -318.6m / Total Assets 78.7m |
| warn (B) unusual magnitude: -4.05 — check mapping/units |
| (C) -0.13 = EBIT TTM -10.6m / Avg Total Assets 84.8m |
| (D) -11.06 = Book Value of Equity -318.6m / Total Liabilities 28.8m |
| Total Rating: -24.32 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 54.99
| 1. Piotroski 5.50pt = 0.50 |
| 2. FCF Yield 3.50% = 1.75 |
| 3. FCF Margin 16.32% = 4.08 |
| 4. Debt/Equity 0.51 = 2.37 |
| 5. Debt/Ebitda 11.22 = -2.50 |
| 6. ROIC - WACC data missing |
| 7. RoE -8.37% = -1.40 |
| 8. Rev. Trend -16.41% = -0.82 |
| 9. Rev. CAGR -7.52% = -1.25 |
| 10. EPS Trend 57.50% = 1.44 |
| 11. EPS CAGR 8.26% = 0.83 |
What is the price of CURI shares?
Over the past week, the price has changed by +5.03%, over one month by +21.22%, over three months by +1.57% and over the past year by +179.23%.
Is Curiositystream a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CURI is around 4.35 USD . This means that CURI is currently overvalued and has a potential downside of -9.38%.
Is CURI a buy, sell or hold?
- Strong Buy: 0
- Buy: 2
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the CURI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 6.2 | 28.5% |
| Analysts Target Price | 6.2 | 28.5% |
| ValueRay Target Price | 4.8 | 0.8% |
Last update: 2025-09-03 04:35
CURI Fundamental Data Overview
CCE Cash And Equivalents = 6.94m USD (Cash And Short Term Investments, last quarter)
P/E Forward = 212.766
P/S = 4.3609
P/B = 5.3233
Beta = 1.759
Revenue TTM = 60.8m USD
EBIT TTM = -10.6m USD
EBITDA TTM = 2.28m USD
Long Term Debt = 4.39m USD (from nonCurrentLiabilitiesTotal, last quarter)
Short Term Debt = 21.2m USD (from shortTermDebt, last quarter)
Debt = 25.6m USD (Calculated: Short Term 21.2m + Long Term 4.39m)
Net Debt = 17.9m USD (from netDebt column, last quarter)
Enterprise Value = 284.0m USD (265.3m + Debt 25.6m - CCE 6.94m)
Interest Coverage Ratio = -4.12 (Ebit TTM -10.6m / Interest Expense TTM 2.58m)
FCF Yield = 3.50% (FCF TTM 9.93m / Enterprise Value 284.0m)
FCF Margin = 16.32% (FCF TTM 9.93m / Revenue TTM 60.8m)
Net Margin = -7.84% (Net Income TTM -4.77m / Revenue TTM 60.8m)
Gross Margin = 53.07% ((Revenue TTM 60.8m - Cost of Revenue TTM 28.6m) / Revenue TTM)
Tobins Q-Ratio = -0.89 (set to none) (Enterprise Value 284.0m / Book Value Of Equity -318.6m)
Interest Expense / Debt = 1.72% (Interest Expense 439.0k / Debt 25.6m)
Taxrate = -17.19% (set to none) (-115.0k / 669.0k)
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = 1.66 (Total Current Assets 40.5m / Total Current Liabilities 24.4m)
Debt / Equity = 0.51 (Debt 25.6m / last Quarter total Stockholder Equity 49.8m)
Debt / EBITDA = 11.22 (Net Debt 17.9m / EBITDA 2.28m)
Debt / FCF = 2.58 (Debt 25.6m / FCF TTM 9.93m)
Total Stockholder Equity = 57.0m (last 4 quarters mean)
RoA = -6.07% (Net Income -4.77m, Total Assets 78.7m )
RoE = -8.37% (Net Income TTM -4.77m / Total Stockholder Equity 57.0m)
RoCE = -17.32% (Ebit -10.6m / (Equity 57.0m + L.T.Debt 4.39m))
RoIC = unknown (NOPAT none, Invested Capital 57.0m, Ebit -10.6m)
WACC = unknown (E(265.3m)/V(290.9m) * Re(8.27%)) + (D(25.6m)/V(290.9m) * Rd(1.72%) * (1-Tc(none)))
Shares Correlation 3-Years: 99.24 | Cagr: 0.76%
Discount Rate = 8.27% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 69.45% ; FCFE base≈9.93m ; Y1≈6.52m ; Y5≈2.98m
Fair Price DCF = 0.97 (DCF Value 56.4m / Shares Outstanding 57.9m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 57.50 | EPS CAGR: 8.26% | SUE: 0.11 | # QB: False
Revenue Correlation: -16.41 | Revenue CAGR: -7.52%
Additional Sources for CURI Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle